India Specialty Chemicals Sector: Q2FY26 Review

A Transition Phase: Domestic Strength Cushioning Export Weakness

India’s specialty chemicals industry continues to operate in a mixed market environment. Export-heavy segments, especially agrochemicals and refrigerants, remain subdued due to prolonged global destocking, regulatory transitions, and tariff disruptions. Meanwhile, domestic demand is visibly recovering, led by construction, FMCG, and institutional consumption.

Despite moderate revenue growth overall, profitability has held up well. A favorable product mix shift toward higher-value, specialty materials has enabled margin expansion in several companies, even as topline resets.

Growth & Profitability: A Divergence Story

Topline prints stayed muted for many players as volumes in global markets remained weak. However, bottom-line performance was resilient as input costs softened and companies shifted toward premium offerings. Pidilite, Vinati, and GFL particularly demonstrated the “mix-led margin defense” playbook effectively — reporting healthy gross and EBITDA margin expansion despite subdued revenue performance.

Domestic demand — especially in B2B construction chemicals, adhesives, and personal/home care surfactants — showed strong sequential improvement. Export recovery appears delayed but signals of stabilization are emerging, setting expectations for a 4Q pickup.

Segment-Level Insights: What’s Working, What’s Not

Agrochemicals remain the softest pocket, where inventory correction in US/EU is taking longer than earlier anticipated. PI Industries continues to feel the brunt with double-digit export declines and uncertain visibility until 4Q.

Fluoropolymers are a bright spot — Gujarat Fluorochemicals benefited strongly from demand in EVs, semiconductors, and specialized engineering industries. The shift from legacy refrigerants (like R-22, R-125) to environment-friendly HFO blends and high-performance PVDF/FKM/PFA grades is both structural and margin accretive.

Performance chemicals and value-added intermediates posted healthy growth for companies like Vinati Organics and Clean Science. Specialty-grade exposure reduced vulnerability to Chinese pricing aggression — although Clean Science’s lower-margin FMCG chemicals remain under pressure.

Carbon black saw a different divergence: strong volumes (PCBL) but pricing/spread compression, due to US tariffs and transient GST-driven demand deferment in India.

Surfactants & EO chemicals grew well for Rossari — export penetration helped volumes — but margins tightened due to EO oversupply and aggressive competition from Asia.

Fine Organics faced export softness and product mix headwinds, though domestic volumes supported stability.

Lastly, Pidilite delivered broad-based strength — with rural and smaller-town consumption holding firm and B2B demand improving along with construction activity.

Capex & Strategic Positioning: Investing Into the Upcycle

A common theme across companies: capex plans remain intact and significant.

Players are deploying capital into:

• new specialty molecules (Vinati, Clean Science, PI Industries)
  
• EV battery materials — salts, PVDF, electrolytes (GFL)
  
• specialty carbon black — for batteries/energy systems (PCBL)
  
• surfactants capacity — Dahej + Unitop addition (Rossari)
  
• rural/B2B and paints expansion (Pidilite)
  

Nearly all these investments are designed to unlock revenue acceleration from FY27 onward, when export recovery and new applications align.

The sector is clearly building capacity for structural, high-value growth segments, not chasing commoditized chemistry.

Company-Wise Snapshot

(Only one table retained per your instruction)

Guidance & Tone From Management

• Export recovery now increasingly seen in 4QFY26 and more fully into FY27
  
• Domestic recovery staying strong — construction, rural markets, FMCG support
  
• Pricing remains disciplined; little appetite for hikes given input price softness
  
• Margins expected to remain stable or improve, driven by:
  
  • premium-grade mix shift
    
  • cost efficiency
    
  • capacity utilization gains ahead
    

Companies are positioning for a volume + margin expansion cycle as new capacities scale and end-markets stabilize.

Conclusion: The Setup Looks Better Than the Prints

The sector is clearly in transition:
📉 short-term softness + muted revenue
vs.
📈 medium-term tailwinds from specialty mix and large strategic capex

Here’s the simplest way to view the next few quarters:

FY26 = reset year
FY27–28 = monetization years

As global demand recovers and premium chemistries form a larger share of revenues, many companies in the space appear poised for re-acceleration in both topline and operating leverage.

Disclaimer: Investment in securities market are subject to market risks. Read all the related documents carefully before investing. Registration granted by SEBI, membership of a SEBI recognized supervisory body (if any) and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

The content in these posts/articles is for informational and educational purposes only and should not be construed as professional financial advice and nor to be construed as an offer to buy /sell or the solicitation of an offer to buy/sell any security or financial products.Users must make their own investment decisions based on their specific investment objective and financial position and using such independent advisors as they believe necessary. Windmill Capital Team: Windmill Capital Private Limited is a SEBI registered research analyst (Regn. No. INH200007645) based in Bengaluru at No 51 Le Parc Richmonde, Richmond Road, Shanthala Nagar, Bangalore, Karnataka – 560025 creating Thematic & Quantamental curated stock/ETF portfolios. Data analysis is the heart and soul behind our portfolio construction & with 50+ offerings, we have something for everyone. CIN of the company is U74999KA2020PTC132398. For more information and disclosures, visit our disclosures page here.